Engineering human stem cells to model the kidneyâs filtration barrier on a chip
Wyss Institute for Biologically Inspired Engineering News May 26, 2017
A glomerulus–on–a–chip lined by human stem cell–derived kidney cells could help model patient–specific kidney diseases and guide therapeutic discovery.
Podocytes are the target of many congenital or acquired kidney diseases, and they are often harmed by drugs.
To build an in vitro model of the human glomerulus that could allow probing deeper into its function, as well as its vulnerabilities to disease and drug toxicities, researchers have been attempting to engineer human stem cells – that in theory can give rise to any mature cell type – so that they form into functional podocytes. These cell culture efforts, however, so far have failed to produce populations of mature podocytes pure enough as to be useful for modeling glomerular filtration.
A team led by Donald Ingber, MD, PhD, at HarvardÂs Wyss Institute for Biologically Inspired Engineering now reports a solution to this challenge in Nature Biomedical Engineering, which enables the differentiation of human induced pluripotent stem (iPS) cells into mature podocytes with more than 90% efficiency. Linking the differentiation process with organ–on–a–chip technology pioneered by his team, the researchers went on to engineer the first in vitro model of the human glomerulus, demonstrating effective and selective filtration of blood proteins and podocyte toxicity induced by a chemotherapy drug in vitro. Ingber is the Wyss InstituteÂs Founding Director, the Judah Folkman Professor of Vascular Biology at Harvard Medical School (HMS) and the Vascular Biology Program at Boston ChildrenÂs Hospital, as well as Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS).
IngberÂs team has engineered multiple organs–on–chips that accurately mimic human tissue and organ–level physiology and that are currently being evaluated by the Food and Drug Administration (FDA) as a tool to more effectively study the effects of potential chemical and biological hazards found in foods, cosmetics or dietary supplements than existing culture systems or animal models. In 2013, his team developed an organ–on–a–chip microfluidic culture device that modeled the human kidneyÂs proximal tubule, which is anatomically connected to the glomerulus and salvages ions from urinary fluid. Now, with the teamÂs newly engineered human kidney glomerulus–on–a–chip, researchers also can get in vitro access to the kidneyÂs core filtration mechanisms that are critical for drug clearance and pharmacokinetics, in addition to studying human podocytes at work.
To generate almost pure populations of human podocytes in cell culture, Samira Musah, PhD, the studyÂs first author and HMS DeanÂs Postdoctoral Fellow who is working with Ingber at the Wyss Institute, leveraged pieces of the stem cell biologists arsenal, and merged them with snippets taken from IngberÂs past research on how cells in the body respond to adhesive factors and physical forces in their tissue environments.
ÂOur method not only uses soluble factors that guide kidney development in the embryo, but, by growing and differentiating stem cells on extracellular matrix components that are also contained in the membrane separating the glomerular blood and urinary systems, we more closely mimic the natural environment in which podocytes are induced and mature, said Musah. ÂWe even succeeded in inducing much of this differentiation process within a channel of the microfluidic chip, where by applying cyclical motions that mimic the rhythmic deformations living glomeruli experience due to pressure pulses generated by each heartbeat, we achieve even greater maturation efficiencies.Â
Go to Original
Podocytes are the target of many congenital or acquired kidney diseases, and they are often harmed by drugs.
To build an in vitro model of the human glomerulus that could allow probing deeper into its function, as well as its vulnerabilities to disease and drug toxicities, researchers have been attempting to engineer human stem cells – that in theory can give rise to any mature cell type – so that they form into functional podocytes. These cell culture efforts, however, so far have failed to produce populations of mature podocytes pure enough as to be useful for modeling glomerular filtration.
A team led by Donald Ingber, MD, PhD, at HarvardÂs Wyss Institute for Biologically Inspired Engineering now reports a solution to this challenge in Nature Biomedical Engineering, which enables the differentiation of human induced pluripotent stem (iPS) cells into mature podocytes with more than 90% efficiency. Linking the differentiation process with organ–on–a–chip technology pioneered by his team, the researchers went on to engineer the first in vitro model of the human glomerulus, demonstrating effective and selective filtration of blood proteins and podocyte toxicity induced by a chemotherapy drug in vitro. Ingber is the Wyss InstituteÂs Founding Director, the Judah Folkman Professor of Vascular Biology at Harvard Medical School (HMS) and the Vascular Biology Program at Boston ChildrenÂs Hospital, as well as Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS).
IngberÂs team has engineered multiple organs–on–chips that accurately mimic human tissue and organ–level physiology and that are currently being evaluated by the Food and Drug Administration (FDA) as a tool to more effectively study the effects of potential chemical and biological hazards found in foods, cosmetics or dietary supplements than existing culture systems or animal models. In 2013, his team developed an organ–on–a–chip microfluidic culture device that modeled the human kidneyÂs proximal tubule, which is anatomically connected to the glomerulus and salvages ions from urinary fluid. Now, with the teamÂs newly engineered human kidney glomerulus–on–a–chip, researchers also can get in vitro access to the kidneyÂs core filtration mechanisms that are critical for drug clearance and pharmacokinetics, in addition to studying human podocytes at work.
To generate almost pure populations of human podocytes in cell culture, Samira Musah, PhD, the studyÂs first author and HMS DeanÂs Postdoctoral Fellow who is working with Ingber at the Wyss Institute, leveraged pieces of the stem cell biologists arsenal, and merged them with snippets taken from IngberÂs past research on how cells in the body respond to adhesive factors and physical forces in their tissue environments.
ÂOur method not only uses soluble factors that guide kidney development in the embryo, but, by growing and differentiating stem cells on extracellular matrix components that are also contained in the membrane separating the glomerular blood and urinary systems, we more closely mimic the natural environment in which podocytes are induced and mature, said Musah. ÂWe even succeeded in inducing much of this differentiation process within a channel of the microfluidic chip, where by applying cyclical motions that mimic the rhythmic deformations living glomeruli experience due to pressure pulses generated by each heartbeat, we achieve even greater maturation efficiencies.Â
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries